ask="1.89"
ask_size="300"
average_daily_volume="162240"
bid="1.44"
bid_size="1900"
book_value="0.39"
change="-0.01"
change_from_200_day_moving_average="-0.04"
change_from_50_day_moving_average="-0.02"
change_from_52_week_high="-0.45"
change_From_52_week_low="0.78"
change_in_percent="-0.65%"
close="1.53"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-0.25"
ebitda="-12.06M"
eps_estimate_current_year="-0.14"
eps_estimate_next_quarter="-0.03"
eps_estimate_next_year="-0.08"
ex_dividend_date="6/24/2005"
float_shares="35315000"
high="1.55"
high_52_weeks="1.98"
last_trade_date="2/8/2017"
last_trade_price="1.53"
last_trade_size="213"
last_trade_time="4:00pm"
low="1.51"
low_52_weeks="0.75"
market_capitalization="103.37M"
moving_average_200_day="1.57"
moving_average_50_day="1.55"
name="Biolase
Inc."
notes="N/A"
one_year_target_price="2.00"
open="1.53"
pe_ratio="N/A"
peg_ratio="-0.54"
percent_change_from_200_day_moving_average="-2.37%"
percent_change_from_50_day_moving_average="-1.44%"
percent_change_from_52_week_high="-22.73%"
percent_change_from_52_week_low="+104.00%"
previous_close="1.54"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.99"
price_per_sales="1.98"
revenue="52.44M"
shares_outstanding="67565000"
short_ratio="29.42"
stock_exchange="NCM"
symbol="BIOL"
volume="18738"
weeks_range_52="0.75 - 1.98"
